Kymera Therapeutics, Inc.

KYMRNASDAQHealthcareBiotechnology

$110.85- (-)1Y +91.91%

As of Oct 22, 2026 close

Market cap: $10.88B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $55.26$130.05
Volume (live): -
Avg. volume (3M): 842.37K

Kymera Therapeutics, Inc. (KYMR) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Kymera Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(11 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$147.90

+33.42% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest KYMR Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 15, 2026	Geoff Meacham	Citi	Maintains	Buy	$150.00
Oct 15, 2026	Derek Archila	Wells Fargo	Maintains	Buy	$151.00
Oct 8, 2026	Thomas Deal	Raymond James	Initiates	Buy	$140.00
Oct 5, 2026	Geoff Meacham	Citi	Maintains	Buy	$135.00 → $150.00 +15.00 (+11.1%)
Sep 28, 2026	Brian Cheng	JP Morgan	Reiterates	Buy	$140.00
Sep 23, 2026	Biren Amin	Piper Sandler	Maintains	Buy	$140.00
Sep 22, 2026	Alex Thompson CFA	Stifel Nicolaus	Maintains	Buy	$132.00 → $152.00 +20.00 (+15.2%)
Sep 14, 2026	Tazeen Ahmad	BofA Securities	Reiterates	Buy	$123.00 → $144.00 +21.00 (+17.1%)
Sep 10, 2026	Andy Chen	Wolfe Research	Upgrades	Buy	$180.00
Sep 2, 2026	Brian Abrahams	RBC Capital	Maintains	Hold	$112.00
Aug 31, 2026	Bradley Canino	Guggenheim	Reiterates	Buy	$135.00 → $170.00 +35.00 (+25.9%)

Geoff Meacham

Citi

BuyMaintains

$150.00

Oct 15

Derek Archila

Wells Fargo

BuyMaintains

$151.00

Oct 15

Thomas Deal

Raymond James

BuyInitiates

$140.00

Oct 8

Geoff Meacham

Citi

BuyMaintains

$135.00 → $150.00

Oct 5

Brian Cheng

JP Morgan

BuyReiterates

$140.00

Sep 28

Biren Amin

Piper Sandler

BuyMaintains

$140.00

Sep 23

Alex Thompson CFA

Stifel Nicolaus

BuyMaintains

$132.00 → $152.00

Sep 22

Tazeen Ahmad

BofA Securities

BuyReiterates

$123.00 → $144.00

Sep 14

Andy Chen

Wolfe Research

BuyUpgrades

$180.00

Sep 10

Brian Abrahams

RBC Capital

HoldMaintains

$112.00

Sep 2

Bradley Canino

Guggenheim

BuyReiterates

$135.00 → $170.00

Aug 31

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for KYMR?

The analyst consensus rating for KYMR is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for KYMR?

The average 12-month price target for KYMR is $147.90, representing an upside of 33.4% from the Oct 22, 2026 close of $110.85.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.